688626 翔宇医疗
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)3.56711.3056.49715.07530.410
总资产报酬率 ROA (%)2.7229.1595.51412.76223.014
投入资产回报率 ROIC (%)3.11410.4686.11514.17423.762

边际利润分析
销售毛利率 (%)66.85668.62166.27468.23067.753
营业利润率 (%)15.77632.84527.72942.80145.074
息税前利润/营业总收入 (%)12.40728.76121.76937.96542.419
净利润/营业总收入 (%)14.48430.65425.23838.11739.557

收益指标分析
经营活动净收益/利润总额(%)77.27888.16556.02673.95478.259
价值变动净收益/利润总额(%)1.7603.80810.2655.444-0.139
营业外收支净额/利润总额(%)-0.913-0.245-1.858-0.601-0.253

偿债能力分析
流动比率 (X)1.8143.2094.7429.4623.357
速动比率 (X)1.4282.5614.1098.5832.706
资产负债率 (%)27.14618.69918.08310.85724.273
带息债务/全部投入资本 (%)12.6181.6584.5370.675--
股东权益/带息债务 (%)648.6835,627.7522,023.87014,295.4611,181.688
股东权益/负债合计 (%)266.239431.387450.141816.587312.079
利息保障倍数 (X)-3.845-7.185-3.992-8.289-16.692

营运能力分析
应收账款周转天数 (天)29.50720.64026.80124.0500.000
存货周转天数 (天)387.731357.501417.574313.3670.000